arrow
Back
O

Olivier Trédan

centre leon berard

55H-index
557Paper Count
1.7WCitation Count
Published Papers 190
Publication Date
Development and validation of a predictive model of aromatase inhibitor-induced arthralgia among patients with early breast cancer
err2026-08-18
err0
PREAI
errPietro Lapidari, MD; Maryam Lustberg, MD, MPH; Julie Havas, MSc; Martina Pagliuca, MD; Chayma Bousrih, MD; Christelle Jouannaud, MD; Marion Fournier, MD; William Jacot, MD, PhD; Laurence Vanlemmens, MD; Kaderbhai Courèche, MD; Anne Kieffer, MD; Baptiste Sauterey, MD; Olivier Tredan, MD, PhD; Christelle Levy, MD; Anne-Laure Martin, PhD; Catherine Gaudin, BSc; Gwenn Menvielle, PhD; Maria Alice Franzoi, MD, PhD; Ines Vaz-Luis, MD, PhD; Antonio Di Meglio, MD, PhD
errShare
errSave
Spatiotemporal organisation of residual disease in mouse and human BRCA1-deficient mammary tumours and breast cancer
err2026-06-11
err0
errOAAI
errDemeter Túrós; Morgane Decollogny; Anna Moyseos; Astrid Chanfon; Myriam Siffert; Joanne Bousmar; Lou Romanens; Jean-Christophe Tille; Olivier Tredan; Intidhar Labidi-Galy; Alberto Valdeolivas; Sven Rottenberg
errShare
errSave
Primary results from EL1SSAR, a prospective phase IIIb study of first-line atezolizumab plus nab-paclitaxel therapy for patients with PD-L1-positive advanced triple-negative breast cancer
err2026-06-08
err0
errOAAI
errL. Gianni; S. Delaloge; E. Ciruelos; O. Trédan; C. Castañeda; M.H. Abreu; I. Paris; M. Colleoni; G. Scandurra; M. Kwiatkowski; N. Antone; V. Gregorc; P. Tagliaferri; S. Borštnar; I. Blancas; M. Raimondo; M. Alfie; C. Arce-Salinas; P.S. Madeira; Y.G. Lin
errShare
errSave
An ERRα-ZEB1 transcriptional signature predicts survival in triple-negative breast cancers
err2026-05-08
err0
errOAAI
errJing-Ru Shi; Coralie Poulard; Catherine Cerutti; Olivier Trédan; Muriel Le Romancer; Tie-Liu Shi; Jean-Marc Vanacker
errShare
errSave
Targeting PRMTs Creates Vulnerability of DNA Double-Stand Break Repair Pathways, and Potentiates Chemotherapy Efficacy in TNBC
err2026-03-09
err0
errOAAI
errCharlène Thiebaut; Sébastien Martinez; Ludivine Pruvost; Louisane Eve; Rania El-Botty; Laura Sourd; Elodie Montaudon; Ahmed Dahmani; Heloise Derrien; Stéphanie Sentis; Coralie Poulard; Elisabetta Marangoni; Olivier Trédan; Muriel Le Romancer
errShare
errSave
Targeting the JAK/STAT Signaling Pathway in Breast Cancer: Leaps and Hurdles
err2025-12-12
err0
errOAAI
errSimon Aho; Clio Coste; Luiza Purcari; Olivier Trédan; Coralie Poulard; Benoite Mery; François-Michel Boisvert; Muriel Le Romancer
errShare
errSave
Durvalumab with carboplatin/paclitaxel and bevacizumab followed by durvalumab and bevacizumab with or without olaparib maintenance in newly diagnosed non-BRCA-mutated advanced ovarian cancer
err2025-12-09
err0
PREAI
errP. Harter; F. Trillsch; A. Okamoto; A. Reuss; J.-W. Kim; M.J. Rubio-Pérez; M.A. Vardar; G. Scambia; O. Trédan; G.-B. Nyvang; N. Colombo; M. Bidziński; C. Grimm; S. Lheureux; E. Van Nieuwenhuysen; F. Heitz; R.M. Wenham; S. Nishio; M.C. Lim; G. Marquina
errShare
errSave
Nivolumab in combination with ipilimumab versus capecitabine as post-operative treatment for triple negative breast cancer patients with residual disease after neoadjuvant chemotherapy: a multicentre, randomized, open-label phase II trial – BREASTIMMUNE-03
err2025-11-21
err0
errOAAI
errOlivier Trédan; Delphine Loirat; Sylvie Chabaud; Philippe Toussaint; Thierry Petit; Frédéric Viret; Christelle Levy; Aurélien Robert; Julien Grenier; Laura Mansi; Jean-Philippe Spano; Anne Patsouris; Olfa Derbel; Christelle Jouannaud; Jean Marc Ferrero; Jean Sébastien Frenel; Yann Molin; Louis Doublet; Pierre-Etienne Heudel; Jean-Yves Pierga
errShare
errSave
Corrigendum to “Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: final overall survival results of MONARCH 3”
err2025-10-15
err0
errOAAI
errM.P. Goetz; M. Toi; J. Huober; J. Sohn; O. Trédan; I.H. Park; M. Campone; S.-C. Chen; L.M. Manso; S. Paluch-Shimon; O.C. Freedman; J. O’Shaughnessy; X. Pivot; S.M. Tolaney; S.A. Hurvitz; A. Llombart-Cussac; V. André; A. Saha; G. van Hal; A. Shahir; H. Iwata; S.R.D. Johnston
errShare
errSave
Risk models of cancer-related cognitive complaints among early breast cancer survivors in the CANTO cohort
err2025-10-01
err0
PREAI
errPresti, Daniele; Di Meglio, Antonio; Havas, Julie; Pagliuca, Martina; Cheaib, Bianca; Martin, Anne-Laure; Gaudin, Catherine; Jouannaud, Christelle; Fournier, Marion; Kieffer, Anne; Campone, Mario; Lerebours, Florence; Petit, Thierry; Boyault, Sandrine; Bertaut, Aurelie; Tredan, Olivier; Cherifi, Francois; Lange, Marie; Pradon, Caroline; Vaz-Luis, Ines; Joly, Florence
errShare
errSave
Effect of breast surgery on quality of life in BRCA mutation carriers with invasive breast cancer: a CANTO database study
err2025-09-04
err0
errOAAI
errKatia MAHIOU; Claire BONNEAU; Charles COUTANT; Anne-Laure MARTIN; Catherine GAUDIN; Marion FOURNIER; William JACOT; Anne KIEFFER; Baptiste SAUTEREY; Olivier TREDAN; Mario CAMPONE; Carole TARPIN; Florence LEREBOURS; Marie-Ange MOURET-REYNIER; Thierry PETIT; Sophie GUILLERMET; Guillaume CONSTANTIN; Aurélie BERTAUT
errShare
errSave
Prognostic Value of a Joint K-PD Model With Tumor Size Dynamics and CA-125 Kinetics in Recurrent Ovarian Cancer Patients: BOLD Phase II GINECO Study
err2025-07-07
err0
errOAAI
errAurore Carrot; Pauline Corbaux; Olivier Colomban; Coriolan Lebreton; Laurence Gladieff; Olivier Tredan; Frédéric Selle; Cyril Abdeddaim; Alexandra Leary
errShare
errSave
Causal analyses of the impact of comorbid conditions and concomitant medications on response to neoadjuvant chemotherapy in breast cancer: analysis of a multicenter prospective cohort study (CANTO)
err2025-05-01
err0
errOAAI
errHamy, A. S.; Grandal, B.; Jochum, F.; Dumas, E.; Sella, N.; Kassara, A.; Barraud, S.; Dubois, T.; Ballesta, A.; Everhard, S.; Lemonnier, J.; Sauzey, M.; Bertaut, A.; Blay, J. - Y.; Cottu, P.; Tredan, O.; Joly, F.; Gougis, P.; Asselain, B.; Latouche, A.; Luis, I. Vaz; Andre, F.; Reyal, F.
errShare
errSave
A bio-behavioral model of systemic inflammation at breast cancer diagnosis and fatigue of clinical importance 2 years later
err2024-11-01
err1
errOAAI
errDi Meglio, A.; Havas, J.; Pagliuca, M.; Franzoi, M. A.; Soldato, D.; Chiodi, C. K.; Gillanders, E.; Dubuisson, F.; Camara-Clayette, V.; Pistilli, B.; Ribeiro, J.; Joly, F.; Cottu, P. H.; Tredan, O.; Bertaut, A.; Ganz, P. A.; Bower, J.; Partridge, A. H.; Martin, A. L.; Everhard, S.; Boyault, S.; Brutin, S.; Andre, F.; Michiels, S.; Pradon, C.; Vaz-Luis, I.
errShare
errSave
Long-term behavioral symptom clusters among survivors of early-stage breast cancer: Development and validation of a predictive model
err2024-09-09
err0
PREAI
errPagliuca, Martina; Havas, Julie; Thomas, Emilie; Drouet, Youenn; Soldato, Davide; Franzoi, Maria Alice; Ribeiro, Joana; Chiodi, Camila K.; Gillanders, Emma; Pistilli, Barbara; Menvielle, Gwenn; Joly, Florence; Lerebours, Florence; Rigal, Olivier; Petit, Thierry; Giacchetti, Sylvie; Dalenc, Florence; Wassermann, Johanna; Arsene, Olivier; Martin, Anne Laure; Everhard, Sibille; Tredan, Olivier; Boyault, Sandrine; De Laurentiis, Michelino; Viari, Alain; Deleuze, Jean Francois; Bertaut, Aurelie; Andre, Fabrice; Vaz-Luis, Ines; Di Meglio, Antonio
errShare
errSave
ENGOT-ov48/EUDARIO: European trial on enhanced DNA repair inhibition in ovarian cancer
err2024-09-01
err0
PREAI
errConcin, N.; Van Gorp, T.; Lorusso, D.; Ray-Coquard, I. L.; Laenen, A.; Zamagni, C.; Harter, P.; Sehouli, J.; Raspagliesi, F.; Zeimet, A. G.; Lotz, J-P.; Salutari, V.; Tredan, O.; Zeillinger, R.; Dobbelstein, M.; Moll, U.; Kramer, D.; Obermayr, E.; Braicu, I.; Vergote, I. B.
errShare
errSave
Validation of circulating tumor DNA for prognostication and monitoring in metastatic endometrial carcinoma: Ancillary results from the phase II randomized GINECO trial UTOLA
err2024-09-01
err0
PREAI
errBeinse, G.; Taly, V.; Leary, A.; Baures, A.; Tredan, O.; You, B.; Rodrigues, M. J.; Gladieff, L.; Lacourtoisie, S. Abadie; Lefevre, L. Bengrine; Brachet, P-E.; Lebreton, C.; Kalbacher, E.; Fournel, P.; Frenel, J-S.; Selle, F.; Largillier, R.; Laurent-Puig, P.; Lobbedez, F. Joly; Alexandre, J.
errShare
errSave
Siremadlin (S) and ribociclib (R) in patients (pt) with advanced well-differentiated/dedifferentiated liposarcomas (WD/DD LPS) and other molecularly selected cancers: Final analysis of the MEGAMOST Ribociclib/HDM201 basket study
err2024-09-01
err0
PREAI
errBrahmi, M.; Tredan, O.; Gomez-Roca, C. A.; Italiano, A.; Saada, E. B.; Bertucci, F.; Le Cesne, A.; Cassier, P.; Treilleux, I.; Chabaud, S.; Garin, G. Fournier; Perol, D.; Blay, J-Y.; Dufresne, A.
errShare
errSave
Development and validation of a predictive model of aromatase inhibitor musculoskeletal toxicity (AIMT) among patients (pts) with early breast cancer (EBC)
err2024-09-01
err0
PREAI
errLapidari, P.; Lustberg, M.; Havas, J.; Pagliuca, M.; Bousrih, C.; Jouannaud, C.; Fournier, M.; Jacot, W.; Vanlemmens, L.; Kaderbhai, C.; Tredan, O.; Levy, C.; Martin, A-L.; Gaudin, C.; Menvielle, G.; Franzoi, M. A.; Luis, I. V. Vaz; Di Meglio, A.
errShare
errSave